Literature DB >> 16417571

Intracellular trafficking in neurones and glia of fibroblast growth factor-2, fibroblast growth factor receptor 1 and heparan sulphate proteoglycans in the injured adult rat cerebral cortex.

W E Leadbeater1, A-M Gonzalez, N Logaras, M Berry, J E Turnbull, A Logan.   

Abstract

The potent gliogenic and neurotrophic fibroblast growth factor (FGF)-2 signals through a receptor complex comprising high-affinity FGF receptor (FGFR)1 with heparan sulphate proteoglycans (HSPGs) as co-receptors. We examined the intracellular dynamics of FGF-2, FGFR1 and the HSPGs syndecan-2 and -3, glypican-1 and -2, and perlecan in neurones and glia in and around adult rat cerebral wounds. In the intact cerebral cortex, FGF-2 and FGFR1 mRNA and protein were constitutively expressed in astrocytes and neurones respectively. FGF-2 protein was localized exclusively to astrocyte nuclei. After injury, expression of FGF-2 mRNA was up-regulated only in astrocytes, whereas FGFR1 mRNA expression was increased in both glia and neurones, a disparity indicating that FGF-2 may act as a paracrine and autocrine factor for neurones and glia respectively. FGF-2 protein localized to both cytoplasm and nuclei of injury-responsive neurones and glia. There was weak or no staining of HSPGs in the normal cerebral neuropil and glia nuclei, with a few immunopositive neurones. Specific HSPGs responded to injury by differentially co-localizing with trafficked intracellular FGF-2 and FGFR1. The spatiotemporal dynamics of FGF-2-FGFR1-HSPG complex formation implies a role for individual HSPGs in regulating FGF-2 storage, nuclear trafficking and cell-specific injury responses in CNS wounds.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16417571     DOI: 10.1111/j.1471-4159.2005.03632.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  24 in total

1.  Heparan sulfate accumulation with Abeta deposits in Alzheimer's disease and Tg2576 mice is contributed by glial cells.

Authors:  Paul O'Callaghan; Elina Sandwall; Jin-Ping Li; Hong Yu; Rivka Ravid; Zhi-Zhong Guan; Toin H van Kuppevelt; Lars N G Nilsson; Martin Ingelsson; Bradley T Hyman; Hannu Kalimo; Ulf Lindahl; Lars Lannfelt; Xiao Zhang
Journal:  Brain Pathol       Date:  2008-04-11       Impact factor: 6.508

2.  Epilepsy-on-a-Chip System for Antiepileptic Drug Discovery.

Authors:  Jing Liu; Anna R Sternberg; Shabnam Ghiasvand; Yevgeny Berdichevsky
Journal:  IEEE Trans Biomed Eng       Date:  2018-09-19       Impact factor: 4.538

3.  Common developmental genome deprogramming in schizophrenia - Role of Integrative Nuclear FGFR1 Signaling (INFS).

Authors:  S T Narla; Y-W Lee; C A Benson; P Sarder; K J Brennand; E K Stachowiak; M K Stachowiak
Journal:  Schizophr Res       Date:  2017-01-13       Impact factor: 4.939

4.  The expression pattern of ADP-ribosyltransferase 3 in rat traumatic brain injury.

Authors:  Wei Shi; Peipei Gong; Jian Fan; Yao Hua Yan; Lanchun Ni; Xiaohong Wu; Gang Cui; Xinmin Wu; Xingxing Gu; Jian Chen
Journal:  J Mol Histol       Date:  2011-10-26       Impact factor: 2.611

Review 5.  Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses.

Authors:  Dao Pan
Journal:  Curr Pharm Biotechnol       Date:  2011-06       Impact factor: 2.837

Review 6.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

7.  Association of the HSPG2 gene with neuroleptic-induced tardive dyskinesia.

Authors:  Aoi Syu; Hiroki Ishiguro; Toshiya Inada; Yasue Horiuchi; Syunsuke Tanaka; Maya Ishikawa; Makoto Arai; Masanari Itokawa; Kazuhiro Niizato; Shuji Iritani; Norio Ozaki; Makoto Takahashi; Akiyoshi Kakita; Hitoshi Takahashi; Hiroyuki Nawa; Kazuko Keino-Masu; Eri Arikawa-Hirasawa; Tadao Arinami
Journal:  Neuropsychopharmacology       Date:  2010-01-13       Impact factor: 7.853

8.  Regulated expression of pancreatic triglyceride lipase after rat traumatic brain injury.

Authors:  Junxia Jia; Meijuan Yan; Zhifang Lu; Maomin Sun; Jianghong He; Chunlin Xia
Journal:  Mol Cell Biochem       Date:  2009-09-17       Impact factor: 3.396

9.  Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons.

Authors:  Alessia Bachis; Alessandra Mallei; Maria Idalia Cruz; Anton Wellstein; Italo Mocchetti
Journal:  Neuropharmacology       Date:  2008-07-18       Impact factor: 5.250

10.  Syndecan-1 and FGF-2, but not FGF receptor-1, share a common transport route and co-localize with heparanase in the nuclei of mesenchymal tumor cells.

Authors:  Fang Zong; Eleni Fthenou; Nina Wolmer; Péter Hollósi; Ilona Kovalszky; László Szilák; Carolin Mogler; Gustav Nilsonne; Georgios Tzanakakis; Katalin Dobra
Journal:  PLoS One       Date:  2009-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.